MYO1E anticorps (N-Term)
Aperçu rapide pour MYO1E anticorps (N-Term) (ABIN5538732)
Antigène
Voir toutes MYO1E AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 228-257, N-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This MYO1E antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 228-257 amino acids from the N-terminal region of human MYO1E.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- For WB starting dilution is: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.44 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- MYO1E (Myosin IE (MYO1E))
-
Autre désignation
- MYO1E
-
Sujet
- Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments (By similarity).
-
Poids moléculaire
- 127 kDa
-
ID gène
- 4643
-
UniProt
- Q12965
-
Pathways
- Platelet-derived growth Factor Receptor Signaling
Antigène
-